Thursday, April 24, 2014  
Sun Biomedical Limited (ASX:SBN)

Jack Kerins

Download MP3 Rate Interview Read Statistics
Interview MP3
 1 time(s)

Mr. Kerins has a 20 year history of successfully transitioning organizations from start up through to successful multi million dollar enterprises

Visit company website

Founded in 1993, Sun Biomedical Laboratories produces both urine and saliva based drugs of abuse testing devices at its facility in Blackwood, New Jersey, U.S.A. The company has established an industry benchmark with the most sensitive saliva drugs of abuse testing device available on the market today. The immediate focus of Sun Biomedical is on the commercialization of drugs of abuse testing devices with a particular emphasis on saliva devices. The company also possesses a portfolio of research into the use of saliva as a diagnostic medium for other disease states that provide the foundation for continued research and development and a broader portfolio of point of care testing devices.

604 VPR Centre
1001 Lower Landing Road Blackwood, NJ 08012
US ph:18884408388 fax:18564011080

Thu, 24 Apr 2014 05:00:51 GMT
Washington University students create medical innovations - 4 hours ago
IDEA Labs, which stands for “innovation, design and engineering in action,” mainly involves students in Washington University's schools of medicine, engineering and applied science - especially its biomedical engineering division. “You want to be ...

Tue, 22 Apr 2014 16:30:00 GMT
Study: New patenting guidelines are needed for biotechnology
R & D Magazine - Apr 22, 2014
Myriad Genetics case raises questions about the patent system,” said Kirstin Matthews, the Baker Institute fellow in science and technology policy and an expert on ethical and policy issues related to biomedical research and development. She co ...

Wed, 23 Apr 2014 18:11:15 GMT
Some Astronauts at Risk for Cognitive Impairment, Animal Studies Suggest - 14 hours ago
A solar flare erupts on the far right side of the sun, in this image captured by NASA's Solar Dynamics Observatory. ... The study, funded by NASA's National Space Biomedical Research Institute, is described in the April issue of the journal Radiation ...

Michael Cintolo
Investments for Cabot Heritage Corp.
Vice President
Read commentary/listen to interview  

John Dessauer
John Dessauer's Investor's World
Editor of the Finacial Newsletter
Read commentary/listen to interview  

Peter Schiff
Euro Pacific Capital, Inc.
President & Chief Global Strategist
Read commentary/listen to interview  


Thu, 24 Apr 2014 08:12:16 GMT
Juicy Apple Buoys Shares, Euro Volatility Sinks

Thu, 24 Apr 2014 08:09:16 GMT
AstraZeneca Flags Cancer Advances, Silent on Pfizer Bid Talk

Thu, 24 Apr 2014 04:11:18 GMT
Anti-Corruption Group Finds Fault With European Union